Neuroprotective effect of tafluprost in glaucoma treatment and its molecular mechanism

Journal Title: Eye Science (Yanke Xuebao) - Year 2024, Vol 39, Issue 6

Abstract

Glaucoma is characterized by the progressive degeneration and loss of retinal ganglion cells (RGC) and their axons, making it one of the most common causes of vision loss. Although the exact underlying mechanisms remain unclear, it is well known that elevated intraocular pressure (IOP) is a major risk factor for the progression of glaucoma. Currently, the primary means of controlling glaucoma involves reducing IOP through medication and surgery. Tafluprost, due to its effective and long-term ability to lower IOP, minimal side effects, high patient compliance, and absence of significant systemic side effects, has become the first-line treatment for primary open-angle glaucoma and ocular hypertension. Recent studies suggest that tafluprost may also have neuroprotective effects beyond its IOP-lowering effects. This article aims to review the pharmacological and potential neuroprotective effects of tafluprost, providing a theoretical basis and research foundation for developing more effective drugs for glaucoma treatment. However, there is still a lack of sufficient clinical evidence to support the neuroprotective effects of tafluprost, and further investigations are required to explore in this field to furnish critical theoretical backing for the development of drugs that target optic nerve protection and facilitate vision restoration through optic nerve regeneration.

Authors and Affiliations

Siting WU, Yiqing LI

Keywords

Related Articles

Research progress on dry eye associated with chronic graft-versus-host disease

Chronic graft-versus-host disease (cGVHD) is one of the most devastating complications following bone marrow transplantation. GVHD develops in 10–80% of patients after hematopoietic stem cell transplantation (HSCT). The...

Application of laryngeal mask airway in obese male patients undergoing ophthalmic day surgery: a retrospective study

[Objective:] General anesthesia using laryngeal mask airway (LMA) ventilation can facilitate ambulatory ophthalmic surgery, however, there remains debates about the use of LMA for obese patients. This study retrospective...

Research progress in the correlation of ocular surface microflora and ocular surface disease

The microbiome of the ocular surface consists of various microbial communities that colonize on the eye surface, mainly bacteria. The stabilization of the microbiome and the other ocular surface components plays an impor...

Research progress on the application of oxybuprocaine hydrochloride eye drops in ophthalmology

Most ophthalmic surgeries are characterized by small incisions and mild pain, therein, the choice of topical anesthesia can meet the needs of surgeries and accelerate ophthalmic surgeries to be conducted in day surgery m...

Changes of refractive statues in infants with retinopathy of prematurity after different treatments

[Objective:] To observe the changes of refractive statues in infants with retinopathy of prematurity retinopathy of prematurity (ROP) after different treatments. [Methods:] According to different treatment methods, 72 ca...

Download PDF file
  • EP ID EP761459
  • DOI 10.12419/24063003
  • Views 35
  • Downloads 0

How To Cite

Siting WU, Yiqing LI (2024). Neuroprotective effect of tafluprost in glaucoma treatment and its molecular mechanism. Eye Science (Yanke Xuebao), 39(6), -. https://www.europub.co.uk/articles/-A-761459